Chronic Disease Costs Have Stalled Economic Growth
Business leaders should track the shift toward continuous care models to mitigate rising workforce productivity losses.
Updated on Sept. 25, 2026 in Healthcare
Live Poll
Do you believe increased investment in healthcare innovation is a reliable driver of national economic growth?
Non-communicable diseases now account for nearly 75 percent of global deaths, impacting roughly 3 billion people. Roche executives warned that these conditions, which remain largely untreated, threaten to shrink global GDP by up to 15 percent annually.
Why it matters
Poor population health directly undermines economic stability and corporate productivity by removing workers from the labor force. Addressing these gaps through continuous care models is critical to maintaining the workforce and financing future health systems.
Non-communicable diseases contribute to 43 million deaths annually among 3 billion chronically ill people. Roche reported CHF 61.5 billion in 2025 group sales and invested CHF 12 billion in research and development to address these health burdens.
The players
Roche
A Basel-based multinational healthcare company operating in pharmaceuticals and diagnostics with a global market presence.
Jörg Rupp
An executive at Roche who advocates for continuous healthcare models to address chronic disease burdens.
The details
Health systems must transition from traditional acute care to continuous, long-term management models to address chronic diseases. This strategy prioritizes early intervention through genetic and environmental innovation to manage disease factors before they result in long-term disability. Healthcare providers and businesses are encouraged to focus on these preventive shifts to stabilize long-term labor participation.
Timeline
1896: Roche was founded in Basel.
2025: Roche reported CHF 61.5 billion in group sales.
September 25, 2026: Jörg Rupp addressed the global health challenge at a media dialogue.
2040: Global GDP is projected to increase by $12 trillion through health innovation.
2050: The global population aged over 65 is projected to triple.
Market Landscape
The global focus on chronic disease management follows a trend of identifying health as a primary macroeconomic indicator rather than just an industry-specific concern. This aligns with projections that aging populations will necessitate major shifts in corporate and government healthcare financing.
Operators should monitor local health service availability as a indicator of future labor force stability. Employers should also evaluate the long-term ROI of wellness initiatives, given the documented economic return on preventive health investments.
The takeaway
Businesses must account for chronic illness as a material risk to workforce availability and regional economic health. Leadership should track innovations in continuous care models as a potential signal for future health system mandates and changes to employer-sponsored care requirements.
Further reading
For broader trends in health sector development, see Healthcare.
Source note: This article includes information reported by @businessline.
Live Poll
Do you believe increased investment in healthcare innovation is a reliable driver of national economic growth?
